Compile Data Set for Download or QSAR
Report error Found 186 Enz. Inhib. hit(s) with all data for entry = 8073
TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232435(US9346795, 208)
Affinity DataIC50: 3.59nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232396(US9346795, 43)
Affinity DataIC50: 3.93nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232408(US9346795, 85)
Affinity DataIC50: 4.19nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232444(US9346795, 258)
Affinity DataIC50: 4.96nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-x...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50384339(CHEMBL2031008 | US9346795, 329)
Affinity DataIC50: 5.09nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50384321(CHEMBL2030856 | US9346795, 245)
Affinity DataIC50: 6.14nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-x...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50384355(CHEMBL2031024 | US9346795, 91)
Affinity DataIC50: 6.27nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-x...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50384329(CHEMBL2030864 | US9346795, 252)
Affinity DataIC50: 6.37nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232450(US9346795, 282)
Affinity DataIC50: 6.97nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232412(US9346795, 106)
Affinity DataIC50: 7.06nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-x...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232397(US9346795, 44)
Affinity DataIC50: 7.25nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232407(US9346795, 84)
Affinity DataIC50: 7.69nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50384318(CHEMBL2030853 | US9346795, 243)
Affinity DataIC50: 7.83nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232434(US9346795, 207)
Affinity DataIC50: 7.84nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232435(US9346795, 208)
Affinity DataIC50: 7.88nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-x...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50384324(CHEMBL2030859 | US9346795, 260)
Affinity DataIC50: 8.01nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-x...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232444(US9346795, 258)
Affinity DataIC50: 8.13nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50384358(CHEMBL2031027 | US9346795, 92)
Affinity DataIC50: 8.41nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232424(US9346795, 181)
Affinity DataIC50: 8.49nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50384340(CHEMBL2031009 | US9346795, 328)
Affinity DataIC50: 8.78nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232433(US9346795, 205)
Affinity DataIC50: 8.85nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-x...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232430(US9346795, 198)
Affinity DataIC50: 8.85nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50384357(CHEMBL2031026 | US9346795, 116)
Affinity DataIC50: 9.01nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-x...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232433(US9346795, 205)
Affinity DataIC50: 9.15nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50384357(CHEMBL2031026 | US9346795, 116)
Affinity DataIC50: 10nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232392(US9346795, 37)
Affinity DataIC50: 10nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-x...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50384329(CHEMBL2030864 | US9346795, 252)
Affinity DataIC50: 10nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-x...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232414(US9346795, 119)
Affinity DataIC50: 10nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-x...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232425(US9346795, 189)
Affinity DataIC50: 10nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50384352(CHEMBL2031021 | US9346795, 53)
Affinity DataIC50: 10nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-x...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232450(US9346795, 282)
Affinity DataIC50: 10nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-x...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50384324(CHEMBL2030859 | US9346795, 260)
Affinity DataIC50: 10nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50384358(CHEMBL2031027 | US9346795, 92)
Affinity DataIC50: 10nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-x...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232432(US9346795, 203)
Affinity DataIC50: 10nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232454(US9346795, 322)
Affinity DataIC50: 10nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232432(US9346795, 203)
Affinity DataIC50: 10nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-x...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232452(US9346795, 289)
Affinity DataIC50: 10nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50384340(CHEMBL2031009 | US9346795, 328)
Affinity DataIC50: 10nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-x...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232386(US9346795, 18)
Affinity DataIC50: 10nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232438(US9346795, 217)
Affinity DataIC50: 10nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232436(US9346795, 213)
Affinity DataIC50: 10nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232396(US9346795, 43)
Affinity DataIC50: 20nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-x...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232421(US9346795, 158)
Affinity DataIC50: 20nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-x...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50384321(CHEMBL2030856 | US9346795, 245)
Affinity DataIC50: 20nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232393(US9346795, 38)
Affinity DataIC50: 20nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-x...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232443(US9346795, 251)
Affinity DataIC50: 20nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232394(US9346795, 39)
Affinity DataIC50: 20nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-x...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50384317(CHEMBL2030852 | US9346795, 242)
Affinity DataIC50: 20nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50384318(CHEMBL2030853 | US9346795, 243)
Affinity DataIC50: 20nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-x...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM232412(US9346795, 106)
Affinity DataIC50: 20nMT: 2°CAssay Description:The assays were performed in black flat-bottom 384-well plates. The final assay volume was 50 μl prepared from additions of Gst-Bcl-2 (Bcl-2: GE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

Displayed 1 to 50 (of 186 total ) | Next | Last >>
Jump to: